{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:17:12Z","timestamp":1767212232620,"version":"3.37.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1124\/jpet.117.242156","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:30:13Z","timestamp":1498177813000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Single Amino Acid Residue at Transmembrane Domain 4 of the \u03b1 Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors"],"prefix":"10.1016","volume":"362","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn H.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.242156_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/mol.65.1.68","article-title":"Defining the propofol binding site location on the GABAA receptor","volume":"65","author":"Bali","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.117.242156_bib3","doi-asserted-by":"crossref","first-page":"e52323","DOI":"10.1371\/journal.pone.0052323","article-title":"A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites","volume":"8","author":"Bergmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.242156_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.drugalcdep.2004.01.007","article-title":"Impairment due to intake of carisoprodol","volume":"74","author":"Bramness","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.117.242156_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.1995.tb17463.x","article-title":"Ligands, receptor models, and evolution","volume":"757","author":"Cockcroft","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.117.242156_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.str.2012.05.003","article-title":"Structure and pharmacology of pentameric receptor channels: from bacteria to brain","volume":"20","author":"Corringer","year":"2012","journal-title":"Structure"},{"key":"10.1124\/jpet.117.242156_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0026-895X(24)12233-X","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1345\/aph.1P339","article-title":"Carisoprodol legal status and patterns of abuse","volume":"44","author":"Fass","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.117.242156_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2011.10.010","article-title":"Carisoprodol tolerance and precipitated withdrawal","volume":"123","author":"Gatch","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.117.242156_bib10","first-page":"180","article-title":"Abuse potential of Soma: the GABA(A) receptor as a target","volume":"1","author":"Gonzalez","year":"2009","journal-title":"Mol Cell Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.109.151142","article-title":"Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies","volume":"329","author":"Gonzalez","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.242156_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino acid difference formula to help explain protein evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"10.1124\/jpet.117.242156_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/npp.2008.89","article-title":"Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists","volume":"34","author":"Heikkinen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.117.242156_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1124\/jpet.117.242156_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0028-3908(02)00175-2","article-title":"Tryptophan scanning mutagenesis in TM4 of the GABA(A) receptor alpha1 subunit: implications for modulation by inhaled anesthetics and ion channel structure","volume":"43","author":"Jenkins","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.117.242156_bib16","unstructured":"Kumar M and Dillon GH (2014) Distinct amino acid domains confer direct gating, allosteric modulation and blocking properties of carisoprodol on GABA(A) receptors (Abstract). Program 124.16\/B31. 2014 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience."},{"key":"10.1124\/jpet.117.242156_bib17","first-page":"1","article-title":"Carisoprodol: update on abuse potential and mechanism of action","volume":"7","author":"Kumar","year":"2015","journal-title":"Mol Cell Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2016.02.031","article-title":"Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors","volume":"775","author":"Kumar","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2015.04.007","article-title":"Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors","volume":"97","author":"Kumar","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.117.242156_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.117.242156_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1124\/jpet.117.242156_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/jm00303a029","article-title":"Carbamate derivatives related to meprobamate","volume":"12","author":"Ludwig","year":"1969","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.117.242156_bib23","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1097\/01.brs.0000146453.76528.7c","article-title":"Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States","volume":"29","author":"Luo","year":"2004","journal-title":"Spine"},{"key":"10.1124\/jpet.117.242156_bib24","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1371\/journal.pmed.0030437","article-title":"The mechanistic classification of addictive drugs","volume":"3","author":"L\u00fcscher","year":"2006","journal-title":"PLoS Med"},{"key":"10.1124\/jpet.117.242156_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature01748","article-title":"Structure and gating mechanism of the acetylcholine receptor pore","volume":"423","author":"Miyazawa","year":"2003","journal-title":"Nature"},{"key":"10.1124\/jpet.117.242156_bib26","doi-asserted-by":"crossref","first-page":"13166","DOI":"10.1074\/jbc.M211905200","article-title":"The GABAA receptor alpha 1 subunit Pro174-Asp191 segment is involved in GABA binding and channel gating","volume":"278","author":"Newell","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242156_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.117.242156_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1874473711003010033","article-title":"Carisoprodol: abuse potential and withdrawal syndrome","volume":"3","author":"Reeves","year":"2010","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1124\/jpet.117.242156_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/SMJ.0b013e31826f5310","article-title":"Carisoprodol: update on abuse potential and legal status","volume":"105","author":"Reeves","year":"2012","journal-title":"South Med J"},{"key":"10.1124\/jpet.117.242156_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1124\/jpet.117.242156_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.117.242156_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.0022-3042.2001.00682.x","article-title":"Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors","volume":"80","author":"Siegwart","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.117.242156_bib33","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242156_bib34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/mol.112.084558","article-title":"State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor","volume":"83","author":"Stewart","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"key":"10.1124\/jpet.117.242156_bib36","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.clinthera.2004.09.008","article-title":"Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone","volume":"26","author":"Toth","year":"2004","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.117.242156_bib37","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.117.242156_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.107.2.195","article-title":"Identification of channel-lining residues in the M2 membrane-spanning segment of the GABA(A) receptor alpha1 subunit","volume":"107","author":"Xu","year":"1996","journal-title":"J Gen Physiol"},{"key":"10.1124\/jpet.117.242156_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-011-2349-6","article-title":"Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers","volume":"218","author":"Zacny","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.117.242156_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pbb.2011.08.011","article-title":"Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers","volume":"100","author":"Zacny","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.117.242156_bib41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1124\/mol.106.030049","article-title":"Identification of a molecular target mediating the general anesthetic actions of pentobarbital","volume":"71","author":"Zeller","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.242156_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2210-7-2","article-title":"Mapping the contribution of beta3-containing GABAA receptors to volatile and intravenous general anesthetic actions","volume":"7","author":"Zeller","year":"2007","journal-title":"BMC Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524196346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524196346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.242156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:57:27Z","timestamp":1739980647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524196346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022356524196346"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.242156","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Single Amino Acid Residue at Transmembrane Domain 4 of the \u03b1 Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.242156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}